Shareholders of Pharming Group NV have formally approved the appointment of Karl Keegan as the company’s new chief financial officer, effective 1 October 2010. The decision was taken at an extraordinary meeting of shareholders which also authorised an increase in the company’s share capital to 500 million shares. Dr Keegan was formerly the chief financial officer of Minster Pharmaceuticals. He has worked in the healthcare industry for more than 15 years.
Copyright 2010 Evernow Publishing Ltd